🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

John W. Davis

The University of Texas MD Anderson Cancer Center

ORCID: 0000-0003-3491-7194
MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 4%percentile
0.863Author DataRank

Indexed papers

2in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Integrative Molecular Analyses of the MD Anderson Prostate Cancer Patient-derived Xenograft (MDA PCa PDX) Series

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-23-2438
Top 29%
0.698DataRank
Top 29%27 citations

Estefanía Labanca, Peter D.A. Shepherd, Jiabin Dong, Jun Yang, Xiaofei Song +20 more

Papers

Driven by 12 papers — median percentile 50. Top paper: “Stromal Senescence following Treatment with the CDK4/6 Inhibitor Palbociclib Alters the Lung Metastatic Niche and Increases Metastasis of Drug-Resistant Mammary Cancer Cells”.

Stromal Senescence following Treatment with the CDK4/6 Inhibitor Palbociclib Alters the Lung Metastatic Niche and Increases Metastasis of Drug-Resistant Mammary Cancer Cells

Cancers(2023)10.3390/cancers15061908
N/A
0.728DataRank · unranked
20 citations

Ghada M. Sharif, Marcel O. Schmidt, B. R. Friedland, Rohith Battina, Raneen Rahhal +5 more

Integrative Molecular Analyses of the MD Anderson Prostate Cancer Patient-derived Xenograft (MDA PCa PDX) Series

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-23-2438
Top 29%
0.698DataRank
Top 29%27 citations

Estefanía Labanca, Peter D.A. Shepherd, Jiabin Dong, Jun Yang, Xiaofei Song +20 more

Caveolin-1-mediated sphingolipid oncometabolism underlies a metabolic vulnerability of prostate cancer

Nature Communications(2020)10.1038/s41467-020-17645-z
N/A
0.666DataRank · unranked
84 citations

Johannes F. Fahrmann, Justin R. Gregg, Zhe Tang, Spyridon P. Basourakos, Ehsan Irajizad +14 more

Expert Perspectives on Controversies in Castration-Sensitive Prostate Cancer Management: Narrative Review and Report of the First US Prostate Cancer Conference Part 1

JU Open Plus(2024)10.1097/ju9.0000000000000137
N/A
0.457DataRank · unranked
8 citations

Alan H. Bryce, Maha Hussain, Neeraj Agarwal, Himisha Beltran, Matthew R. Cooperberg +33 more

Expert Perspectives on Controversies in Metastatic Castration-Resistant Prostate Cancer Management: Narrative Review and Report of the First US Prostate Cancer Conference Part 2

JU Open Plus(2024)10.1097/ju9.0000000000000138
N/A
0.208DataRank · unranked
3 citations

E. David Crawford, Neeraj Agarwal, Maha Hussain, Himisha Beltran, Matthew R. Cooperberg +33 more

Integrative analysis of the MD Anderson Prostate Cancer Patient-Derived Xenograft Series (MDA PCa PDX)

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.07.21.500652
Top 70%
0.165DataRank
Top 70%2 citations

Estefanía Labanca, Xiaofei Song, Jun Yang, Peter D.A. Shepherd, Jiabin Dong +18 more

Development and Validation of an Objective Scoring Tool to Evaluate Surgical Dissection: Dissection Assessment for Robotic Technique (DART)

Urology Practice(2021)10.1097/upj.0000000000000246
N/A
0DataRank · unranked
17 citations

Runzhuo Ma, Jacqueline Maya-Silva, Daniel I. Sanford, Jessica H. Nguyen, Xiaomeng Lei +24 more

Oncologic outcomes among Black and White men with grade group 4 or 5 (Gleason score 8‐10) prostate cancer treated primarily by radical prostatectomy

Cancer(2021)10.1002/cncr.33419
N/A
0DataRank · unranked
14 citations

Jeffrey J. Tosoian, Chad A. Reichard, Debasish Sundi, Weranja Ranasinghe, Ridwan Alam +9 more

Increased body mass index is associated with operative difficulty during robot‐assisted radical prostatectomy

BJUI Compass(2021)10.1002/bco2.110
N/A
0DataRank · unranked
10 citations

John W. Davis, Wendell H. Williams, Brian F. Chapin, John F. Ward, Curtis A. Pettaway +2 more

A phase Ib trial of enzalutamide with venetoclax in metastatic castration-resistant prostate cancer (mCRPC).

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.tps5599
N/A
0DataRank · unranked
2 citations

Jason Kirk, John W. Davis, Saby George, Ellis Levine, Jan H. Beumer +4 more

Neoadjuvant apalutamide (APA) plus leuprolide (LHRHa) with or without abiraterone (AA) in localized high-risk prostate cancer (LHRPC).

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.5504
N/A
0DataRank · unranked
18 citations

Myrto Boukovala, Nicholas Spetsieris, Sijin Wen, Anh Hoang, Justin A. Weldon +15 more

A Multi-institution Study on the Association of Virtual Reality Skills with Continence Recovery after Robot-assisted Radical Prostatectomy

European Urology Focus(2023)10.1016/j.euf.2023.05.011
N/A
0DataRank · unranked
12 citations

Elyssa Y. Wong, Runzhuo Ma, Cherine H. Yang, Istabraq S. Dalieh, Alvin Hui +9 more